RARE   $58.35  -0.73% Market Open

Ultragenyx Pharmaceutical Inc
Total Cash 763.82M
totalCashPerShare 8.293
EBITDA -515.74M
Total Debt 926.54M
quickRatio 3.196
currentRatio 3.535
Total Revenue 481.30M
debtToEquity 214.269
Revenue/Share 5.946
ROA -0.23417
ROE -2.08433
grossProfits
freeCashflow -275.98M
operatingCashflow -469.47M
earningsGrowth
revenueGrowth 0.357
grossMargins -0.4952
ebitdaMargins -1.07155
operatingMargins -0.79143
profitMargins -1.2157
enterpriseValue 5.57B
forwardPE -11.405826
floatShares 88.85M
sharesOutstanding 92.17M
sharesShort 3.51M
sharesShortPriorMonth 4.23M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.99%
Short Ratio help_outline 4.45%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 4.697
Price To Book help_outline 12.51
earningsQuarterlyGrowth
netIncomeToCommon -585.12M
trailingEps -7.21%
forwardEps -5.15%
enterpriseToEbitda -10.80
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.43 3Q 2024
institutionsCount 396
lastUpdated Sept. 16, 2024, noon